Literature DB >> 29183723

SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling.

Hao Yang1, Xiao Zhang1, Fang Liu1, Jirong Fan1, Bolin Wang1, Chuanjiang Dong2.   

Abstract

Clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancers, is an incurable and lethal disease. Although great progresses have been made in understanding the mechanism of ccRCC, metabolic reprogramming in ccRCC remains largely unclear. Here, we showed that lipid desatutation might be a metabolic hallmark of ccRCC. We demonstrated sterol regulatory element-binding protein 1 (SREBP1) is overexpressed in ccRCC cell lines and positively correlated with NF-κB activation. Further, SREBP1 is required for lipid desaturation and cell growth in ccRCC. Mechanistically, we demonstrated that SREBP1-driven lipid desaturation promotes NF-κB activation. Our finding reveals a crucial roles for SREBP1 in lipid desaturation of ccRCC through regulation of NF-κB signaling, which provides not only new insights in regulatory mode of NF-κB signaling but also a novel target for potential metabolic therapies.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Clear cell renal cell carcinoma; Lipid desaturation; Lipid metabolism; NF-κB; SREBP1

Mesh:

Substances:

Year:  2017        PMID: 29183723     DOI: 10.1016/j.bbrc.2017.11.163

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  SREBP1 promotes 5-FU resistance in colorectal cancer cells by inhibiting the expression of caspase7.

Authors:  Yuyan Gao; Qi Zhao; Xiaoqin Mu; Huifen Zhu; Binbin Liu; Bingqing Yao; Xinyi Liu; Wenhan Xue; Bo Wang; Shulin Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

2.  Deletion of SREBF1, a Functional Bone-Muscle Pleiotropic Gene, Alters Bone Density and Lipid Signaling in Zebrafish.

Authors:  Chen Shochat; Zhiying Wang; Chenglin Mo; Sarah Nelson; Rajashekar Donaka; Jian Huang; David Karasik; Marco Brotto
Journal:  Endocrinology       Date:  2021-01-01       Impact factor: 4.736

3.  Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.

Authors:  Xiaohong Ma; Tianyi Zhao; Hong Yan; Kui Guo; Zhiming Liu; Lina Wei; Wei Lu; Chunping Qiu; Jie Jiang
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

Review 4.  The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.

Authors:  Yongcan Xu; Mantang Qiu; Minmin Shen; Shunli Dong; Guochao Ye; Xuefei Shi; Ming Sun
Journal:  Mol Ther       Date:  2021-03-26       Impact factor: 12.910

5.  MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.

Authors:  Yi Ding; Jie Yang; Yawen Ma; Tengteng Yao; Xingyu Chen; Shengfang Ge; Lihua Wang; Xianqun Fan
Journal:  J Exp Clin Cancer Res       Date:  2019-12-19

6.  ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.

Authors:  Ken Tanaka; Shuya Kandori; Shotaro Sakka; Satoshi Nitta; Kozaburo Tanuma; Masanobu Shiga; Yoshiyuki Nagumo; Hiromitsu Negoro; Takahiro Kojima; Bryan J Mathis; Toru Shimazui; Makoto Watanabe; Taka-Aki Sato; Takafumi Miyamoto; Takashi Matsuzaka; Hitoshi Shimano; Hiroyuki Nishiyama
Journal:  Oncol Rep       Date:  2021-11-29       Impact factor: 3.906

7.  Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.

Authors:  Cancan Zhou; Weikun Qian; Jiguang Ma; Liang Cheng; Zhengdong Jiang; Bin Yan; Jie Li; Wanxing Duan; Liankang Sun; Junyu Cao; Fengfei Wang; Erxi Wu; Zheng Wu; Qingyong Ma; Xuqi Li
Journal:  Cell Prolif       Date:  2018-10-19       Impact factor: 6.831

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.